Transplant-associated thrombotic microangiopathy (TMA) leads to generalized endothelial
dysfunction that can progress to multiorgan injury, and severe cases are associated with poor …

The Sickle Cell Unrelated Donor Transplant Trial (SCURT trial) of the Blood and Marrow
Transplant Clinical Trials Network (BMT CTN) is a phase II study of the toxicity and efficacy of …

Eighty 11‐year‐old pupils (40 males and 40 females) from an urban primary school were
assessed for cognitive style by means of the Cognitive Styles Analysis which indicated their …

Adenovirus infection in immunocompromised patients contributes to significant morbidity and
死亡率,尤其是alloge之后neic hematopoietic cell transplantation (HCT). Brincidofovir …

Fifty‐two children with symptomatic sickle cell disease sickle cell disease (SCD) (N = 43) or
transfusion‐dependent thalassemia (N = 9) received matched sibling donor marrow (46), …

Patients with mutations of the recombination-activating genes (RAG) present with diverse
clinical phenotypes, including severe combined immune deficiency (SCID), autoimmunity, and …

PURPOSE: Severe (grade 3-4) acute graft-versus-host disease (AGVHD) is a major cause
of death after unrelated-donor (URD) hematopoietic cell transplant (HCT), resulting in …

Pediatric patients with SCID constitute medical emergencies. In the absence of an HLA-identical
hematopoietic stem cell (HSC) donor, mismatched related-donor transplantation (…

To the Editor: Autoinflammatory syndromes are caused by dysregulation of the innate immune
system, often affecting the inflammasome and other pathogen recognition pathways that …

We describe our retrospective clinical experience with ruxolitinib for steroid-refractory acute
graft-versus-host disease (GVHD) in pediatric allogeneic hematopoietic stem cell transplant (…